Retinoid-X receptors and the effects of 9-cis-retinoic acid on insulin secretion from RINm5F cells☆

Abstract 

Retinoid-X receptors (RXRs) are 9-cis-retinoic acid (9CRA)-dependent gene transcription factors, which modulate the action of all-trans-retinoic acid (ATRA), fatty acids, thyroid hormone (TH), and vitamin D (VD) by forming dimers with themselves or ATRA, TH, peroxisome proliferator activator receptors (PPARs), or VD receptors (VDRs). To determine if 9CRA and RXRs have a role in secretion, RINm5F cells were assayed for RXR transcripts and effects of 9CRA and ATRA on secretion. A single RXRα transcript and two RXRβ transcripts, but not RXRγ, were evident by Northern blot. Cells were cultured for 48 hours without and with 9CRA 1 to 1,000 nmol/L and then stimulated with glucose 0, 0.5, 2.8, 7, and 11 mmol/L. 9CRA increased secretion at each glucose concentration. 9CRA increased secretion by 50% to 100% (ANOVA, P < .001) with consistent concentration-dependent responses (eg, at glucose 2.8 mmol/L, 9CRA: 0 nmol/L, 5.02 ± .20 ng/(10⁶ cells · h); 1 nmol/L, 6.97 ± .30; 10 nmol/L, 8.36 ± .18; 100 nmol/L, 9.15 ± .28; 1,000 nmol/L, 10.24 ± .24; n = 6). Although RINm5F cells respond slightly if at all to glucose, 9CRA facilitated glucose-induced insulin release (eg, at 9CRA 100 nmol/L, glucose: 0.5 mmol/L, 7.47 ± .22 ng/(10⁶ cells · h); 2.8 mmol/L, 9.15 ± .27; 7 mmol/L, 9.81 ± .19; 11 mmol/L, 11.16 ± .23; n = 6). ATRA increased secretion by 28% to 57% (ANOVA, P < .001: at glucose 2.8 mmol/L, ATRA: 0 nmol/L, 6.17 ± .32 ng/(10⁶ cells · h); 1 nmol/L, 7.91 ± .29; 10 nmol/L, 9.75 ± .14; 100 nmol/L, 9.66 ± .33; n = 6). 9CRA was more potent than ATRA (eg, at 2.8 mmol/L: baseline, 6.17 ± .32 ng/(10⁶ cells · h); ATRA 100 nmol/L, 9.66 ± .33; 9CRA 100 nmol/L, 10.81 ± .15; P < .05, n = 6). When 9CRA was combined with ATRA, the combination was not additive or synergistic (eg, at 2.8 mmol/L: ATRA 100 nmol/L, 9.66 ± .33 ng/(10⁶ cells · h); 9CRA 100 nmol/L, 10.81 ± .15; ATRA 100 nmol/L + 9CRA 100 nmol/L, 10.79 ± .28; P < .05, n = 6). These studies show that (1) 9CRA stimulates insulin secretion from RINm5F cells. This effect appears to be at least equal to if not greater than that observed with ATRA, but additive or synergistic effects with ATRA were not evident; (2) 9CRA may facilitate glucose-induced release; and (3) multiple RXR transcripts are present in insulin-secreting cells, implying specific functions. Our findings support the idea that the effects of 9CRA on insulin secretion are mediated through RXR homodimers or heterodimers with retinoic acid receptors (RARs) or possibly other nuclear receptors. Retinoid deficiency or alterations in retinoid receptor function could lead to abnormalities of cell growth or secretion.

No full text is available. To read the body of this article, please view the PDF online.